Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review

Glucose impairment is common in preterm infants but the impact of early neonatal hyperglycemia on long term neurodevelopment is still highly controversial. This review reports current evidence of the effect of hyperglycemia on neurodevelopmental outcome. It was conducted according to the PRISMA guid...

Full description

Bibliographic Details
Main Authors: Silvia Guiducci, Leonardo Meggiolaro, Anna Righetto, Marco Piccoli, Eugenio Baraldi, Alfonso Galderisi
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/9/10/1541
_version_ 1827650950325600256
author Silvia Guiducci
Leonardo Meggiolaro
Anna Righetto
Marco Piccoli
Eugenio Baraldi
Alfonso Galderisi
author_facet Silvia Guiducci
Leonardo Meggiolaro
Anna Righetto
Marco Piccoli
Eugenio Baraldi
Alfonso Galderisi
author_sort Silvia Guiducci
collection DOAJ
description Glucose impairment is common in preterm infants but the impact of early neonatal hyperglycemia on long term neurodevelopment is still highly controversial. This review reports current evidence of the effect of hyperglycemia on neurodevelopmental outcome. It was conducted according to the PRISMA guidelines. We searched MEDLINE via PubMed; EMBASE via Ovid; the Cochrane Central Register of Controlled Trials; the Cochrane Library; ClinicalTrials.gov; and the World Health Organization’s International Trials Registry and Platform. We included studies that investigated the association between hyperglycemia, defined as at least one episode of glycemia ≥8 mmol/L, and neurodevelopment outcome evaluated either through the Griffiths Mental Developmental Scales (GMDS) or the Bayley Scales of Infant Development (BSID) for the first 5 years of life, and the Wechsler Intelligence Scale for Children (WISC) and the Movement Assessment Battery for Children (MABC) for the following age category. We selected six studies, comprising 2226 infants in total and which included 1059 (48%) infants for whom neurodevelopment assessment was available. We found an association between hyperglycemia and neurological delay in the first two years of life, especially for motor functions; this result was confirmed in later childhood. The quality of evidence was poor; therefore, the negative influence of neonatal hyperglycemia on the neurological development of preterm infants must be investigated in further studies.
first_indexed 2024-03-09T20:27:15Z
format Article
id doaj.art-7741a472f4d94184b5676dd307ff74f7
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-09T20:27:15Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-7741a472f4d94184b5676dd307ff74f72023-11-23T23:32:38ZengMDPI AGChildren2227-90672022-10-01910154110.3390/children9101541Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A ReviewSilvia Guiducci0Leonardo Meggiolaro1Anna Righetto2Marco Piccoli3Eugenio Baraldi4Alfonso Galderisi5Departement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyDepartement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyDepartement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyDepartement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyDepartement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyDepartement of Woman’s and Child’s Health, University of Padova, 35128 Padova, ItalyGlucose impairment is common in preterm infants but the impact of early neonatal hyperglycemia on long term neurodevelopment is still highly controversial. This review reports current evidence of the effect of hyperglycemia on neurodevelopmental outcome. It was conducted according to the PRISMA guidelines. We searched MEDLINE via PubMed; EMBASE via Ovid; the Cochrane Central Register of Controlled Trials; the Cochrane Library; ClinicalTrials.gov; and the World Health Organization’s International Trials Registry and Platform. We included studies that investigated the association between hyperglycemia, defined as at least one episode of glycemia ≥8 mmol/L, and neurodevelopment outcome evaluated either through the Griffiths Mental Developmental Scales (GMDS) or the Bayley Scales of Infant Development (BSID) for the first 5 years of life, and the Wechsler Intelligence Scale for Children (WISC) and the Movement Assessment Battery for Children (MABC) for the following age category. We selected six studies, comprising 2226 infants in total and which included 1059 (48%) infants for whom neurodevelopment assessment was available. We found an association between hyperglycemia and neurological delay in the first two years of life, especially for motor functions; this result was confirmed in later childhood. The quality of evidence was poor; therefore, the negative influence of neonatal hyperglycemia on the neurological development of preterm infants must be investigated in further studies.https://www.mdpi.com/2227-9067/9/10/1541neonatal glucosehyperglycemiapreterm infantneurodevelopmental outcomeneurodevelopment impairment
spellingShingle Silvia Guiducci
Leonardo Meggiolaro
Anna Righetto
Marco Piccoli
Eugenio Baraldi
Alfonso Galderisi
Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
Children
neonatal glucose
hyperglycemia
preterm infant
neurodevelopmental outcome
neurodevelopment impairment
title Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
title_full Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
title_fullStr Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
title_full_unstemmed Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
title_short Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
title_sort neonatal hyperglycemia and neurodevelopmental outcomes in preterm infants a review
topic neonatal glucose
hyperglycemia
preterm infant
neurodevelopmental outcome
neurodevelopment impairment
url https://www.mdpi.com/2227-9067/9/10/1541
work_keys_str_mv AT silviaguiducci neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview
AT leonardomeggiolaro neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview
AT annarighetto neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview
AT marcopiccoli neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview
AT eugeniobaraldi neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview
AT alfonsogalderisi neonatalhyperglycemiaandneurodevelopmentaloutcomesinpreterminfantsareview